Ses Ai Corp
5 nominees · 3 ballot items.
Election of the Class III director nominee; ratification of Grant Thornton LLP as independent registered public accounting firm; and non-binding advisory vote on executive compensation to be held at the 2025 Annual Meeting of SES AI Corporation.
Follow how the vote landed and what changed on Ses Ai Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of the Class III director nominee
ManagementBoard: FORElection of the Class III director to serve a three-year term; nominee is Dr. Qichao Hu.
- 2
Ratification of the appointment of Grant Thornton LLP as the independent registered public accounting firm
ManagementBoard: FORRatification of Grant Thornton LLP to serve as the independent registered public accounting firm for fiscal year 2025.
- 3
Non-binding vote on executive compensation
ManagementBoard: FORNon-binding advisory vote to approve the compensation of the named executive officers for fiscal 2024 as disclosed in the proxy statement.
Nominees on the ballot5
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 2.6% | 9,471,108 | $9M |
| 2 | Invesco Ltd. | 2.1% | 7,895,246 | $8M |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 1.2% | 4,596,252 | $4M |
| 4 | BlackRock, Inc. | 1.2% | 4,534,476 | $4M |
| 5 | MILLENNIUM MANAGEMENT LLC | 0.9% | 3,180,655 | $3M |
| 6 | Temasek Holdings (Private) Ltd | 0.9% | 3,160,712 | $3M |
| 7 | STATE STREET CORP | 0.8% | 3,038,810 | $3M |
| 8 | General Motors Holdings LLC | 0.8% | 2,921,950 | $3M |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 0.7% | 2,602,703 | $3M |
| 10 | GOLDMAN SACHS GROUP INC | 0.7% | 2,523,335 | $2M |
Other Consumer Cyclical sector meetings6
Upcoming shareholder meetings at Ses Ai Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Ses Ai Corp 2025 annual meeting?
- Ses Ai Corp (SES) holds its 2025 annual shareholder meeting on Wednesday, October 1, 2025.
- What is the record date for the Ses Ai Corp 2025 meeting?
- The record date for the Ses Ai Corp 2025 meeting is Monday, August 25, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Ses Ai Corp's 2025 meeting?
- The board is presenting 5 director nominees at the Ses Ai Corp 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Ses Ai Corp 2025 meeting?
- Shareholders will vote on 3 proposals at the Ses Ai Corp 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.